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Spatial regulation of ERK1/2 MAP kinases is an essential
yet largely unveiled mechanism for ensuring the ﬁdelity
and speciﬁcity of their signals. Mxi2 is a p38a isoform
with the ability to bind ERK1/2. Herein we show that
Mxi2 has profound effects on ERK1/2 nucleocytoplasmic
distribution, promoting their accumulation in the nucleus.
Downregulation of endogenous Mxi2 by RNAi causes a
marked reduction of ERK1/2 in the nucleus, accompanied
by a pronounced decline in cellular proliferation. We
demonstrate that Mxi2 functions in nuclear shuttling
of ERK1/2 by enhancing the nuclear accumulation of
both phosphorylated and unphosphorylated forms in the
absence of stimulation. This process requires the direct
interaction of both proteins and a high-afﬁnity binding
of Mxi2 to ERK-binding sites in nucleoporins, In this
respect, Mxi2 acts antagonistically to PEA15, displacing
it from ERK1/2 complexes. These results point to Mxi2
as a key spatial regulator for ERK1/2 and disclose an
unprecedented stimulus-independent mechanism for
ERK nuclear import.
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Introduction
ERK1 and ERK2 mitogen-activated protein kinases (MAPKs)
are cytoplasmic kinases that become activated in response
to a wide array of stimuli, including those that regulate
cell proliferation, differentiation and survival. ERK1/2 are
key elements in the transduction of signals from the surface
to the interior of the cell. They lie downstream of a signaling
module that includes sequentially Raf family MAPKKKs
and MEK 1 and 2 dual-speciﬁcity MAPKKs. This cascade
is regulated at its origin by Ras GTPases. Once activated,
ERK1/2 phosphorylate a broad spectrum of substrates dis-
tributed throughout different subcellular compartments
(Pearson et al, 2001). The balance among these site-speciﬁc
components of ERK signals is the determinant for the biolo-
gical outcomes resulting from ERK activation (Robinson et al,
1998; Ajenjo et al, 2004).
Under resting conditions, unphosphorylated ERK1/2 are
primarily located in the cytoplasm, largely as a consequence
of their interaction with cytoplasmic anchors, including
MEK1, certain protein phosphatases and the cytoskeleton
(Reszka et al, 1995; Fukuda et al, 1997b; Blanco-Aparicio
et al, 1999). Upon stimulation, ERK1/2 lose afﬁnity for these
partners and redistribute throughout the cell, including
the nucleus. Phosphorylation may be sufﬁcient to promote
ERK1/2 transit to the nucleus, but their kinase activity is not
necessary (Lenormand et al, 1993). Several models explain-
ing ERK1/2 nuclear import have been suggested: ERK1/2
enter the nucleus, in both phosphorylated and unphosphory-
lated forms, by a carrier- and energy-independent mechanism
that involves direct interaction with the nuclear pore complex
(NPC) (Matsubayashi et al, 2001; Whitehurst et al, 2002). The
phosphorylated proteins may also enter the nucleus, perhaps
in a dimeric form, by active transport (Khokhlatchev et al,
1998; Adachi et al, 1999; Ranganathan et al, 2006). Some
proteins, like PEA15, prevent ERK1/2 translocation by inter-
fering with their binding to the nuclear pore (Formstecher
et al, 2001; Whitehurst et al, 2004). ERK1/2 nucleocytoplas-
mic distribution is also dependent on its nuclear export.
ERK1/2 nuclear efﬂux can be mediated by MEK, which
has a nuclear export sequence (NES) that complexes with
the nuclear export receptor CRM1 (Fukuda et al, 1997a).
ERK1/2, once dephosphorylated in the nucleus, bind to
MEK and are exported to the cytoplasm (Adachi et al,
2000). ERK1/2 nucleocytoplasmic distribution can also be
affected by the number and afﬁnity of ERK1/2 binding
partners in each compartment (Pouyssegur and Lenormand,
2003; Burack and Shaw, 2005). ERK1/2 nuclear translocation
and retention requires neosynthesis of nuclear anchoring
proteins (Lenormand et al, 1993). Topoisomerase II and
kinetochores have been identiﬁed as nuclear anchors for
ERK1/2 (Shapiro et al, 1998), but the identity of the majority
of these remains elusive.
Mxi2 is a splice isoform of p38a. It is identical to p38 from
amino acids 1 to 280 and harbors a unique, 17-amino-acid
C-terminus (Zervos et al, 1995). We have recently reported
that some Mxi2 biochemical properties make it unique
among p38 proteins (Sanz et al, 2000). As such, Mxi2 directly
binds to ERK1/2 and in so doing it prolongs their activation.
This interaction has profound effects on ERK1/2 nuclear but
not cytoplasmic signaling (Sanz-Moreno et al, 2003). Herein,
we have studied the mechanism of Mxi2 action on ERK1/2
functions. We report that Mxi2 is a nuclear protein with the
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ability to alter ERK1/2 nucleocytoplasmic distribution by
facilitating ERK1/2 nuclear entry. In the absence of additional
stimulation, Mxi2 expression is sufﬁcient to promote ERK1/2
nuclear translocation. Our results disclose for the ﬁrst time a
stimulus-independent nuclear shuttle for ERK1/2 capable
of modifying ERK1/2 nucleocytoplasmic distribution.
Results
Mxi2 is a nuclear protein
To gain an initial insight into how Mxi2 regulates ERK1/2
functions, we investigated its subcellular distribution.
Mxi2 was expressed in COS7 cells and its localization was
visualized by immunoﬂuorescence. Mxi2 was predominantly
nuclear irrespective of the stimulatory conditions, although
particularly when cells were growing or under acute mito-
genic stimulation (Figure 1A). Quantiﬁcation of Mxi2 nuclear
and cytoplasmic fractions conﬁrmed that, under starvation,
over 60% of Mxi2 was nuclear and that this proportion was
greater than 80% when growing or upon stimulation with
EGF (Figure 1B). The possibility existed that Mxi2 nuclear
localization was a consequence of its inability to interact with
cytoplasmic MAPKKs. Thus, cells were cotransfected with
HA-tagged Mxi2 or p38 together with MKK3 or MKK6 and the
presence of these MAPKKs in the anti-HA immunoprecipi-
tates was analyzed. It was found that both MAPKKs efﬁ-
ciently associated with Mxi2, although in the case of MKK3
not as intensely as with p38 (Figure 1C). Furthermore, over-
expression of these MAPKKs resulted in a pronounced retrie-
val of Mxi2 from the nucleus (Supplementary Figure 1).
Mxi2 alters ERK1/2 subcellular distribution
Next, we investigated how Mxi2 affected ERK1/2 distribution
between the nucleus and cytoplasm. In parental COS7 cells,
under resting conditions, nearly 20% of the total ERK1/2
pool was nuclear. This proportion increased to B50% under
mitogenic stimulation, upon which phosphorylated ERK1/2
also segregated evenly between the nucleus and the cyto-
plasm (Figure 2A). Conversely, in cells transfected with Mxi2,
about 80% of ERK1/2 was nuclear under basal conditions,
a proportion that increased to over 90% under EGF stimula-
tion. In line with our previous results (Sanz-Moreno et al,
2003), the presence of Mxi2 was sufﬁcient to increase the
levels of phosphorylated ERK1/2 even under starved condi-
tions, the majority of which was located in the nucleus. On
Figure 1 Subcellular localization of Mxi2. COS7 cells transfected with HA-Mxi2 (1 mg), serum-starved, growing or stimulated with EGF
(100ng/ml, 5min) were analyzed for Mxi2 distribution as follows: (A) Anti-HA immunoﬂuorescence and confocal microscopy. Scale bar:
10mm. (B) Nucleocytoplasmic fractionation: Determined by anti-HA immunoblotting in nuclear (N) and cytoplasmic (C) fractions. Figures
show the percentage of Mxi2 present in each compartment. The absence of cross-contamination in N and C extracts was ascertained using
nuclear (Elk, Lamin A) and cytoplasmic (Rho-GDI) markers. (C) Interaction of Mxi2 with MAPKKs. Cells were transfected with HA-p38 or HA-
Mxi2, plus FLAG-tagged MKK3 or MKK6 (1 mg each). Lysates were immunoprecipitated with anti-HA antibody (I) or preimmune serum (P) and
probed for associated MKK 3 or 6. Protein levels were determined by anti-HA immunoblotting. TL¼ total lysate.
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the other hand, in cells transfected with Mxi2 D17, a mutant
form that cannot bind ERK1/2 (Sanz-Moreno et al, 2003), the
localization of total and phosphorylated ERK1/2 closely
resembled that detected in control cells. This suggested
that direct binding to Mxi2 was required for ERK1/2 redis-
tribution. These observations were conﬁrmed by immuno-
ﬂuorescence. In serum-starved control cells, ERK1/2 were
pronouncedly cytoplasmic (Figure 2B). By contrast, in cells
expressing Mxi2, ERK1/2 underwent a dramatic nuclear
translocation where they markedly colocalized with Mxi2
(Figure 2C).
In MDCK cells, endogenous Mxi2 acts as a nuclear tether
for ERK1/2
The above results had the limitations inherent to every
ectopic expression system. Thus, it was essential to ascertain
whether the same phenomena applied under physiological
conditions. We generated an antibody that speciﬁcally recog-
nized Mxi2 and, upon screening some cell lines, we found
that the canine renal epithelium cell line MDCK endo-
genously expressed Mxi2 at high levels (Supplementary
Figure 2). When we examined the nucleocytoplasmic
distribution of endogenous Mxi2 in MDCK cells, it was
found primarily at the nucleus, under starved and stimulated
conditions (Figure 3A), mirroring the results obtained by
ectopic expression in COS7 cells.
We wished to know whether endogenous Mxi2 inﬂuenced
ERK1/2 distribution. To do so, we downregulated its expres-
sion in MDCK cells by means of RNA interference. Because
the canine sequence for the region encoding Mxi2 C-termi-
nus, exon 110, had not been described, we sequenced it using
DNA from MDCK cells. The resultant sequence (GenBank
accession number DQ388883) had a 98% identity with
the human one. Next, oligonucleotides encoding for an
siRNA targeting Mxi2 at the region encoding amino acids
282–287 were cloned into a short-hairpin plasmid and stably
expressed in MDCK cells. We obtained a pool of 10 clones
named MDMx, in which Mxi2 expression was undetectable
and p38 were unaffected (Figure 3B). In cells expressing
random control siRNAs, neither Mxi2 nor p38 expression
were affected (data not shown). Next, we investigated
the impact of Mxi2 downregulation on ERK1/2 distribution.
In MDCK cells whether starved, growing or stimulated
with EGF, both total and phosphorylated ERK1/2 were pro-
minently nuclear, a pattern almost identical to that found
in COS7 cells transfected with Mxi2. Conversely, in
MDMx cells, ERK1/2 were distributed more evenly between
the nucleus and cytoplasm, and the amounts of nuclear,
phosphorylated ERK1/2 were lower (Figure 3C), resembling
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Figure 2 Mxi2 alters ERK1/2 nucleocytoplasmic distribution. (A) Lysates from COS7 cells transfected with vector (control) or HA-Mxi2, wild
type and D17 (1mg); starved, growing or EGF-stimulated (100 ng/ml, 5min) were separated into nuclear (N) and cytoplasmic (C) fractions.
Protein levels were analyzed by immunoblotting. Figures show the percentage of ERK1/2 present in each compartment. Right panel: expression
levels of Mxi2 wild type and D17. (B, C) Mxi2 tethers ERK1/2 to the nucleus. Mxi2 and ERK1/2 distributions were determined by anti
HA-Texas Red/ERK-FITC Red immunoﬂuorescence in serum-starved (control) and HA-Mxi2-transfected cells. DAPI staining revealed nuclei.
Scale bar: 10mm.
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parental COS7 cells. These results were conﬁrmed by immuno-
ﬂuorescence. In parental MDCK cells, Mxi2 was markedly
nuclear, excluded from nucleoli and mainly found at the
nucleoplasm, where it profusely colocalized with ERK1/2
(Figure 3D). On the other hand, in MDMx cells, suppression
of Mxi2 expression resulted in a decrease in the nuclear
ERK1/2, which became more uniformly distributed through-
out the cell (Figure 3E). These results indicated that Mxi2,
whether ectopic or endogenous, was capable of profoundly
altering ERK1/2 distribution by promoting its localization to
the nucleus.
It was important to gain a notion of the physiological
consequences of ERK1/2 nucleocytoplasmic redistribu-
tion resulting from Mxi2 downregulation. To this end,
we compared the growth kinetics of MDCK and MDMx
cells. In MDCK cells, the MEK inhibitor UO126 abrogated
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Figure 3 Mxi2 is expressed endogenously in MDCK cells. (A) Nucleocytoplasmic distribution of Mxi2: Lysates from cells starved, growing
or stimulated with EGF (100 ng/ml, 5min) were separated in nuclear (N) and cytoplasmic (C) fractions. Mxi2 distribution was determined by
immunoblotting. Figures show the percentage of Mxi2 present in each compartment. (B) Down-regulation of Mxi2 expression in MDCK cells by
RNAsi. Mxi2 protein levels in parental MDCK and in MDMx cells, in which Mxi2 expression was suppressed, were determined by anti-Mxi2
and anti-p38 (N-terminal) immunoblotting. (C) Downregulation of Mxi2 alters ERK1/2 nucleocytoplasmic distribution. Lysates from MDCK
and MDMx cells, starved, growing or stimulated with EGF, were separated into nuclear (N) and cytoplasmic (C) fractions. Figures show the
percentage of ERK1/2 present in each compartment. Distribution of endogenous Mxi2 and ERK1/2 in (D) MDCK cells and (E) MDMx cells, as
determined by anti ERK-FITC/Mxi2-Texas Red immunoﬂuorescence. Scale bar: (G) 15 mm; (H) 10 mm.
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proliferation, indicating that this process was dependent on
ERK activation (Figure 4A). Noticeably, the proliferation rate
in MDMx cells was reduced by nearly 40%. To verify that
such a decrease on proliferative capacity was due to the
drop on ERK1/2 nuclear levels and not to some unrelated
Mxi2-mediated effect, we generated a cell line derived from
MDMx cells (Mx-EN) expressing an ERK2 harboring
SV40 NLS at its C-terminus, to bolster its accumulation in
the nucleus (Figure 3A, inset). It was found that in Mx-EN
cells, the restoration of ERK nuclear levels rescued cellular
proliferation up to levels similar to those exhibited by
parental MDCK cells.
We then took an insight into how Mxi2 affected ERK
distribution under pathological conditions. To this aim, we
looked at several samples of renal adenocarcinomas.
Interestingly, in the tumor samples, Mxi2 was markedly
overexpressed and they possessed much higher phospho-
ERK levels, as compared with healthy renal tissue from the
same individuals (Figure 4B, left panel). When evaluating
ERK1/2 distribution, it was found that in the tumors both
total and phosphorylated ERK1/2 accumulated mainly at the
nucleus, as opposed to healthy tissue in which they were
mainly cytoplasmic (Figure 4B, right panel). These results
veriﬁed that under pathological conditions, Mxi2 also acted
as a nuclear tether for ERK1/2.
Mxi2 potentiates ERK1/2 binding to nuclear pore
proteins
The mechanism whereby Mxi2 made possible the accumula-
tion of ERK1/2 at the nucleus was explored. One possibility
was that Mxi2 could be interfering with ERK1/2 nuclear
export, thereby prolonging its residence therein. To test this
hypothesis, as it has been suggested that ERK1/2 leave the
nucleus associated to MEK (Adachi et al, 2000), we analyzed
whether Mxi2 had an effect on MEK nucleocytoplasmic
shuttling. We found that the expression of Mxi2 was incap-
able of altering MEK nucleocytoplasmic distribution in COS7
cells, neither under basal conditions (Figure 5A) nor under
EGF stimulation (Supplementary Figure 3). In MDCK cells,
in which, unlike COS7 cells, MEK is mainly located at the
cytoplasm, downregulation of endogenous Mxi2 did not
have any noticeable effect on MEK distribution either
(Supplementary Figure 3).
Another possibility was that Mxi2 potentiated ERK1/2
nuclear entry. As it has been shown that ERK1/2 interact
with the NPC to gain access to the nucleus (Matsubayashi
et al, 2001; Whitehurst et al, 2002), we investigated if Mxi2
could impact this interaction. We expressed the C-terminus of
nucleoporin 153 (Whitehurst et al, 2002) as a GST fusion and
tested in vitro its binding to ERK1/2 in lysates from cells
transfected with increasing concentrations of Mxi2. As shown
in Figure 5B, ERK1/2 were found to bind to GST-Nup153c
per se, as previously shown (Whitehurst et al, 2002).
Interestingly, Mxi2 markedly augmented the amount of
ERK1/2 bound to the nucleoporin. To gain a quantitative
notion of this effect, increasing concentrations of puriﬁed
ERK2 were allowed to bind in vitro to GST-Nup153c in the
presence or absence of Mxi2 and bound ERK2 was recovered
by afﬁnity pull-down. As shown in Figure 5C, the afﬁnity of
ERK2 towards the nucleoporin (KdB90nM) increased nearly
two-fold (KdB50nM) in the presence of Mxi2. Mxi2-mediated
enhancement of ERK1/2 afﬁnity for Nup 153 was dependent
on the ability of Mxi2 to bind ERK1/2, because only wild-type
Mxi2 could exert this effect. Contrarily, Mxi2 D17 and E293A,
two mutants defective for binding to ERK1/2 (Sanz-Moreno
et al, 2003; our unpublished results), were unable to potentiate
the interaction of ERK1/2 with the NPC protein, even though
these mutants could themselves bind to Nup153c as effectively
as wild-type Mxi2 (Figure 5D). These results demonstrate that
Mxi2 itself can directly bind to the NPC, and that the presence
of Mxi2 in Nup153 afﬁnity pull-downs (Figure 5B) was not a
consequence of its interaction with ERK but rather with the
nucleoporin itself. To further substantiate this point, we eval-
uated Mxi2 in vitro binding afﬁnity towards Nup153, following
the same methodology described above. As shown in
Figure 5E, Mxi2 displayed a remarkable afﬁnity (Kd¼ 58nM)
towards this nuclear pore component.
Mxi2 antagonizes PEA15
It has been shown that the cytoplasmic protein PEA15
(Formstecher et al, 2001) interferes with ERK1/2 binding to
the nuclear pore, thereby preventing their nuclear import
(Whitehurst et al, 2004). As such, it was of interest to explore
if Mxi2 could counteract PEA15 effects. As expected,
expression of PEA15 in COS7 cells markedly prevented
the accumulation of total and phosphorylated ERK1/2 in
the nucleus upon stimulation with EGF. Conversely, when
expressed together with Mxi2, PEA15 no longer interfered
Hours in culture
Ce
lls
/p
la
te
(×1
03
)
A
B Healthy
1 2 1 2
α ERK
α pERK
α Mxi2
Tumor
α ERK
Healthy Tumor
N1 N2 C1 C2 N1 N2 C1 C2
0 12 24 36 48 60 72
0
20
40
60
80
MDCK
MDMx–
Mx-EN
+UO126
α Mxi2
α ERK
Nuc
Cyt
α pERK
Figure 4 Mxi2 expression associated to cellular proliferation and
transformation. (A) Downregulation of Mxi2 expression slows
cellular proliferation. Proliferation rates of the cells lines indicated
in the legend, growing in 10% calf serum. Where indicated, MDCK
cells were grown in the presence of 2mM UO126. Results show
average7s.e.m. of at least three independent experiments. Inset:
Mxi2 expression and ERK1/2 nucleocytoplasmic distribution in the
starved cell lines indicated by symbols. (B) Mxi2 expression and
ERK1/2 distribution in renal tumors. Left panel: Lysates from two
adenocarcinomas (tumor 1 and 2) and from healthy renal tissue of
the same individuals (healthy 1 and 2) were analyzed by immuno-
blotting. Right panel: Lysates from the tumor and healthy samples
were fractionated into nuclear (N) and cytoplasmic (C) fractions
and analyzed by immunoblotting.
Mxi2, a nuclear shuttle for ERK1/2
B Casar et al
&2007 European Molecular Biology Organization The EMBO Journal VOL 26 | NO 3 | 2007 639
with ERK1/2 nuclear transit, neither under starvation nor
after EGF stimulation (Figure 6A), suggesting that Mxi2 and
PEA15 had antagonistic effects on ERK1/2 nuclear import, and
that Mxi2 could overcome the inhibitory effects of PEA15. To
extend this observation, we investigated whether Mxi2 and
PEA15 would compete for binding to ERK1/2. PEA15 was
expressed with AU5-tagged ERK2 in addition to increasing
concentrations of Mxi2 and its presence in anti-AU5 immuno-
precipitates was analyzed. It was found that the amount of
PEA15 detected in association with ERK2 decreased concomi-
tantly with the increasing appearance of Mxi2 in ERK2 com-
plexes (Figure 6B), thus supporting the conclusion that Mxi2
competes with PEA15 to associate with ERK1/2.
It has been shown that PEA15 interacts with ERK2 through
the Insert region (Whitehurst et al, 2004); so we asked if
PEA15 and Mxi2 shared this common binding site for binding
to ERK1/2. To this aim, we coexpressed Mxi2 with an ERK2
Insert region deletion mutant (D241–272) (Whitehurst et al,
2004) and assayed their ability to complex. It was found that
ERK2 D241–272 associated with Mxi2 to a much lesser extent
than wild-type ERK2 (Figure 6C), suggesting that the Insert
region was an essential site for Mxi2 binding to ERK2. The
possibility existed that the deletion of the whole Insert region
introduced gross conformational changes on ERK2 so as to
perturb Mxi2 binding. To rule out this possibility, we tested
the ability of Mxi2 to bind to an ERK2 point mutant within
this region, Y261N, previously shown to be defective for
binding to PEA15 (Whitehurst et al, 2004). As shown in
Figure 6C, Mxi2 association to this ERK2 mutant form was
remarkably impaired. These experiments demonstrated that
Mxi2 and PEA15 shared a common ERK2-binding site.
Mxi2 is a stimulus-independent nuclear shuttle
for ERK1/2
As Mxi2 was able to facilitate ERK1/2 binding to the NPC, we
asked if, by this mechanism, Mxi2 would be sufﬁcient to
Figure 5 Mxi2 affects ERK1/2 nuclear import. (A) The expression of Mxi2 does not affect MEK distribution. Lysates from control () and
Mxi2-transfected (þ ) COS7 cells were separated in nuclear and cytoplasmic fractions and MEK levels were analyzed by immunoblotting.
(B) Mxi2 potentiates ERK1/2 interaction with nucleoporins. Lysates from COS7 cells transfected with increasing amounts (0.25–2mg) of Mxi2
were incubated with GST Nup153c or GST (G) beads. ERK1/2 and Mxi2 levels in pull-downs were analyzed by immunoblotting. (C) Mxi2
increases ERK1/2 in vitro afﬁnity for Nup 153c. Increasing concentrations of puriﬁed ERK2 were incubated with 200nM GST-Nup153c, with or
without 100nM Mxi2 as shown. ERK2 bound to Nup153 was afﬁnity pulled-down and quantiﬁed. Results show average of three independent
experiments. (D) Mxi2 mutants defective for binding ERK1/2 do not promote ERK association to the NPC. Lysates from cells transfected with HA-
Mxi2 wild-type (wt) and mutants D17 and E293 (1mg), were incubated with GST Nup153c beads. Proteins in the pull-downs were analyzed by
immunoblotting. (E) Mxi2 binds Nup 153c in vitro. Increasing concentrations of puriﬁed Mxi2 were incubated with 200nM GST-Nup153c. Bound
Mxi2 was afﬁnity pulled-down and quantitated. Results show average of three independent experiments. PD, afﬁnity precipitates; TL, total lysates.
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drive ERK1/2 into the nucleus in the absence of additional
stimuli known to promote ERK1/2 nuclear translocation. To
this end, we utilized a conditional vector in which Mxi2
expression was regulated by the zinc-inducible metallothio-
nein promoter. Once transfected into COS7 cells and after
serum starvation, ZnSO4 was added to induce the expression
of Mxi2, which was apparent after 12 h. As expected, the
majority of the newly expressed Mxi2 accumulated in
the nucleus (Figure 7A). Noticeably, concomitant with the
appearance of Mxi2, ERK1/2 underwent a dramatic redistri-
bution, translocating from the cytoplasm to the nucleus. On
the other hand, the expression of Mxi2 E293A did not affect
ERK1/2 distribution, in spite of itself being able to enter
the nucleus. The possibility existed that Mxi2 could promote
ERK1/2 nuclear entry by inducing the expression of some
growth factor and thereby, an autocrine loop that would
induce ERK nuclear import. However, conditioned media
from Mxi2-transfected COS7 cells and from MDCK cells failed
to stimulate ERK1/2 nuclear translocation (data not shown),
suggesting that this was not the case. These results clearly
supported the notion that Mxi2 could sufﬁce to promote the
transport ERK1/2 to the nucleus in the absence of further
stimulation, and that a direct interaction between Mxi2 and
ERK1/2 was essential for this process.
To conﬁrm that Mxi2-induced ERK1/2 nuclear transloca-
tion proceeded through the nuclear pore, we utilized wheat
germ agglutinin (WGA), which binds to N-acetylglucosamine
residues on nucleoporins, thus preventing all transit that
requires interactions with the nuclear pore (Finlay et al,
1987). Treatment with WGA completely abrogated nuclear
entrance of both Mxi2 and ERK1/2 (Figure 7B). To implicate
an active transport mechanism in the import of the Mxi2–
ERK complex, we utilized the GTPase-deﬁcient mutant Ran
Q69L that inhibits active nuclear transport in a dominant-
negative manner (Adachi et al, 1999). The presence of
Ran Q69L completely inhibited the nuclear accumulation of
ERK1/2 triggered by Mxi2 expression (Figure 7C). Neither
treatment with WGA nor expression of Ran Q69L affected
Mxi2 binding to ERK1/2 (Supplementary Figure 4). These
results are consistent with the idea that the Mxi2–ERK
complex entered the nucleus by a mechanism that required
Ran-mediated active transport. The nuclear entry of Mxi2
itself was also blocked, suggesting that its nuclear inﬂux also
occurs by an active import mechanism.
The fact that Mxi2 could induce ERK1/2 nuclear transloca-
tion in the absence of stimulation implied that ERK1/2
transported into the nucleus was an unphosphorylated
state. To verify that Mxi2 was indeed capable of promoting
nuclear import of unphosphorylated ERK1/2, we utilized an
ERK2 mutant (AEF) in which the phosphoacceptor threonine
and tyrosine had been mutated to alanine and phenylalanine
respectively, rendering it unphosphorylatable (Wolf et al,
2001). Upon cotransfection into COS7 with the Zn-inducible
Mxi2 construct, it was found that Mxi2 could evoke the
nuclear translocation of ERK2-AEF just as efﬁciently as that
of wild-type ERK2 (Figure 7D), demonstrating that Mxi2 was
capable of inducing the nuclear translocation of unphos-
phorylated ERK1/2.
It has been shown that phosphorylated ERK1/2 forms
dimers, and it is likely that dimerization plays a role in their
nuclear translocation (Khokhlatchev et al, 1998). Thus, it was
interesting to test whether Mxi2-dependent nuclear transloca-
tion required ERK1/2 dimerization. For this, we utilized the
ERK2 mutant H176 L4A (HL), defective for dimerization
(Khokhlatchev et al, 1998). It was found that Mxi2 co-immu-
noprecipitated with ERK2-HL (Supplementary Figure 5), in-
dicating that Mxi2 could form a complex with monomeric
ERK2. Moreover, upon cotransfecting ERK2-HL with the Zn-
inducible Mxi2 construct in COS7 cells, we found that Mxi2
could efﬁciently promote nuclear translocation of ERK2-HL
(Figure 7E), thus demonstrating that dimerization was not a
requirement for Mxi2-mediated ERK1/2 nuclear translocation.
As it has been suggested that in the absence of stimulation,
ERK1/2 are retained in the cytoplasm largely as a result of their
interaction with cytoplasmic anchors such as MEK1 (Fukuda
et al, 1997b), it was conceivable that a mechanism whereby
Mxi2 could induce stimulation-independent ERK1/2 nuclear
translocation could be by liberating ERK1/2 from their cyto-
plasmic partners. To test this possibility, we analyzed if Mxi2
could release ERK1/2 from their complex with MEK. Increasing
concentrations of Mxi2 were expressed in COS7 cells and the
amounts of ERK1/2 associated with MEK were evaluated. As
shown in Figure 7F, in spite of the gradual increase on Mxi2
cellular concentration, the levels of ERK1/2 in association with
MEK were unaffected. This result supported the notion that
Mxi2 did not affect ERK–MEK complex stability.
Reconstitution in a permeabilized cell system was then
used to examine the effect of Mxi2 on individual steps in
A
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C Δ241–272 Y261NMyc-:
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IP: α HA
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Figure 6 Mxi2 antagonizes PEA15. (A) Mxi2 counteracts PEA15-
mediated blockade of ERK1/2 nuclear translocation. Vector (con-
trol) and HA-Mxi2 were trasfected, with or without FLAG-PEA15,
into COS7 cells. After starvation and stimulation with EGF where
indicated, lysates were separated into nuclear and cytoplasmic
fractions. Protein levels were analyzed by immunoblotting.
(B) Mxi2 outcompetes PEA15 for binding to ERK1/2. COS7 were
transfected with AU5-ERK2 and FLAG-PEA15 (1mg each) along with
increasing concentrations of Mxi2 (0.25–2mg). PEA15 and Mxi2 in
anti-AU5 immunoprecipitates were determined by immunoblotting.
(C) Mxi2 requires the Insert region for binding to ERK2. HA-Mxi2 was
cotransfected into COS7 cells with Myc-tagged ERK2 wild type, the
Insert region-defective mutant D241–272 or the point mutant Y261A
(1mg each). ERK2 in anti-HA immunoprecipitates was determined by
immunoblotting. TL, total lysates; IP, immunoprecipitates.
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the nucleocytoplasmic shuttling of unphosphorylated ERK2.
Permeabilized cells lose most transport factors and Ran; thus,
a complementation assay with cytosol as the source of
transport factors was used to investigate ERK2 nuclear
uptake and export. In the absence of cytosol and energy,
GFP-ERK2 was imported in the in vitro import assay as
previously shown (Matsubayashi et al, 2001; Whitehurst
et al, 2002). Under these same conditions, addition of in-
A
ZnSO4
ZnSO4
ZnSO4
ZnSO4
ZnSO4
0 1 6 12 24 36 0 1 6 12 24 36 h
wt E293A
B
α Mxi2
α ERK
TL
TL
Cyt
Cyt
Nuc
Nuc
Cyt
Cyt
Nuc
Nuc
Cyt
Cyt
Nuc
Nuc
Cyt
Nuc
TL
Cyt
Nuc
α Mxi2
Mxi2
C
0 12 24 36 h 0 12 24 36 h
WGA Ran QL
α ERK
ERK2
α HA
D
0 1 6 12 24 36 0 1 6 12 24 36 h
HA-wt HA-AEF
Myc-HL
0 1 6 24 36 h
E
TL
IP
IP
α HA
α MEK
α ERK
IP: αMEK −− HA-Mxi2F
Figure 7 Mxi2 is a nuclear shuttle for ERK1/2. (A) Mxi2 expression is sufﬁcient to promote ERK1/2 nuclear translocation. COS7 cells were
transfected with Zn-inducible vectors expressing Mxi2 wild type (wt) and E293A. After 18 h of serum starvation, 75 mM ZnSO4 was added and
cells were incubated for the indicated periods. Lysates were separated into nuclear and cytoplasmic fractions and protein levels were analyzed
by immunoblotting. (B) Effects of WGA on the nuclear import of the ERK–Mxi2 complex. Cells were transfected with the Zn-inducible Mxi2.
After starvation, ZnSO4 was added. WGA (40mg/ml) was added after 6 h. Lysates were fractionated and protein levels were analyzed by
immunoblotting. (C) Effects of a Ran inhibitory mutant on the nuclear import of the ERK–Mxi2 complex. Cells were transfected with the Zn-
inducible Mxi2 and a vector expressing Ran Q69L (1mg). After starvation, ZnSO4 was added. Lysates were fractionated and protein levels were
analyzed. (D) Mxi2 promotes nuclear entry of unphosphorylated ERK1/2. COS7 cells were transfected with the HA-Mxi2 Zn-inducible vector in
addition to plasmids encoding for HA-ERK2 or HA-ERK2 AEF (1mg each), and MEK (1.5mg) to serve as a cytoplasmic anchor. After starvation,
ZnSO4 was added. Lysates were fractionated and protein levels were analyzed by anti-HA immunoblotting. (E) Mxi2 translocates monomeric
ERK2 into the nucleus. Cells were cotransfected with the Mxi2 Zn-inducible vector plus Myc-tagged ERK2 H176 L4A dimerization-defective
mutant (HL) (1mg). After starvation, ZnSO4 was added. Lysates were fractionated and analyzed by anti-Myc immunoblotting. (F) Mxi2
cannot displace ERK1/2 from ERK–MEK complexes. Cells were transfected with increasing concentrations of HA-Mxi2 (0.25–2mg). Endogenous
ERK1/2 present in anti-MEK immunoprecipitates was determined by immunoblotting. IP, immunoprecipitates; TL, total lysates.
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creasing concentrations of Mxi2 reduced the import of GFP-
ERK2 (Figure 8A and B), suggesting that Mxi2 did not enter
the nucleus without energy and transport factors. ERK2
import may have been reduced either due to binding to
Mxi2 under circumstances in which Mxi2 could not translo-
cate to the nucleus or due to Mxi2 competing with ERK2 for
binding to nucleoporins. In order to clarify this point, we
tested whether Mxi2 E293A could outcompete ERK1/2 from
binding to nucleoporins, by analyzing the amounts of ERK1/2
that associated to GST-Nup153 in the presence of increasing
concentrations of this ERK binding-defective Mxi2 mutant. It
was found that the quantity of ERK1/2 bound to the nucleo-
porin markedly diminished, in parallel to the increase of Mxi2
E293A in the Nup153 afﬁnity pull-downs (Figure 8C), thus
demonstrating that Mxi2 and ERK1/2 competed for the same
binding sites in Nup153.
Finally, to test the idea that ERK2 binding to Mxi2 was
inﬂuencing the distribution of ERK2, GFP-ERK2 was imported
into the nucleus with or without Mxi2, plus or minus cytosol
and energy. The import mixture was removed and ERK2 was
allowed to be exported for 15min. It was found that more
GFP-ERK2 remained in the nucleus of the cells that have had
Mxi2 imported with cytosol (Figure 8D and E), supporting the
idea that Mxi2 binds tightly enough to ERK2 to cause its
retention in the compartment to which it is localized.
Discussion
In this study, we explored the regulation of ERK1/2 by Mxi2. We
have found that Mxi2, both ectopically expressed and endogen-
ous, localizes predominantly to the nucleus. Mxi2 accumulation
in the nucleus is not due to its inability to interact with putative
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Figure 8 Effects of Mxi2 on ERK2 nuclear import/export in the digitonin permeabilization in vitro nuclear import assay, in BJ ﬁbroblasts.
(A) Import of GFP-ERK2 is not increased in the absence of cytosol for the import of Mxi2. Nuclear import of GFP-ERK2 (1.5 mg) was performed
in transport buffer without cytosol or energy, plus or minus two different concentrations of Mxi2 as shown. (B) Quantiﬁcation of two
independent experiments (average7s.d.). (C) Mxi2 outcompetes ERK1/2 for binding to nucleoporins. Lysates from COS7 cells transfected with
Mxi2 E293A (0.25–2mg) were incubated with GST Nup153c. Afﬁnity precipitates (PD) and total lysates (TL) were analyzed by immunoblotting.
Figures show percentage ERK binding relative to the value in control cells. (D) Nuclear ERK2 levels increase when Mxi2 is imported into the
nucleus in the presence of cytosol and energy. Where indicated, Mxi2 (1.5mg) was ﬁrst incubated under import conditions for 15min, either
with or without cytosol and energy. After washing, import of GFP-ERK2 was carried out for 15min in the absence of cytosol and energy,
followed by a 15-min export assay. (E) Quantiﬁcation of three independent experiments (average7s.d.). AU, arbitrary units.
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cytoplasmic anchors, as Mxi2 is capable of interacting with
MKK 3 and 6. We have observed that upon stimulation, Mxi2 is
enriched further in the nucleus, unlike p38 that exits the
nucleus once activated (Ben-Levy et al, 1998). This difference
may be due to Mxi2 being unable to interact with MAPKAP K2
(our unpublished results), which acts as a p38 nuclear exit
shuttle (Ben-Levy et al, 1998). Maybe the inability of Mxi2 to
couple to this or similar nuclear export mechanisms could
contribute to its persistent nuclear localization.
Our results demonstrate that Mxi2 expression evokes a
dramatic redistribution of ERK1/2 from the cytoplasm to the
nucleus. This is highlighted when examining the endogenous
proteins in MDCK cells, in which downregulation of Mxi2 by
RNAi results in a marked drop in ERK1/2 nuclear localization.
Furthermore, Mxi2 enhances the accumulation of total and
phosphorylated ERK1/2 in the nucleus, even under starvation.
Our ﬁndings suggest that Mxi2 binding to ERK1/2 hinders their
interaction with deactivating phosphatases (Sanz et al, 2000;
Sanz-Moreno et al, 2003; unpublished results). Our results
herein hint that Mxi2 could be inhibiting ERK1/2 nuclear but
not cytoplasmic phosphatases, since, even though about 20%
of Mxi2 is localized at the cytoplasm, this fraction seems
unable to affect the levels of phosphorylated ERK1/2 therein.
One possible explanation could be that Mxi2 afﬁnity for ERK1/
2 is higher than that of nuclear phosphatases, but lower than
the afﬁnity exhibited by cytoplasmic phosphatases. Thus, only
a high concentration of Mxi2 could bring about changes in
ERK1/2 cytoplasmic signals.
Searching for the mechanisms underlying in Mxi2 effects
on ERK1/2 nucleocytoplasmic distribution, we have found
that Mxi2 markedly potentiates ERK1/2 binding to nucleo-
porin 153. This requires a direct interaction between Mxi2
and ERK1/2, as Mxi2 mutants defective for binding to ERK1/
2 are unable to enhance either their association with nucleo-
porins or their translocation into the nucleus. It seems
possible that this effect of Mxi2 contributes to enhance the
nuclear entry of ERK1/2. However, in vitro import assays
suggest that this effect is not sufﬁcient in the absence of
nuclear entry of Mxi2 itself. As such, the possibility of Mxi2
also serving as some sort of nuclear anchor for ERK1/2
should be considered. Another implication is that the inter-
action of Mxi2 with ERK2 may cause conformational changes
in ERK2 that affect its capacity to interact with other proteins.
Changes in interactions with phosphatases, for example, may
be one manifestation of this effect.
It has been proposed that ERK1/2 bind to nucleoporins at
the FXF motifs (Jacobs et al, 1999) present in many of these,
through a hydrophobic region proximal to the activation lip
(Lee et al, 2004; Whitehurst et al, 2004). We show that Mxi2
itself can directly bind to nucleoporin 153. The ERK1/2
hydrophobic residues thought to mediate the NPC interaction
are conserved in p38a/Mxi2. Thus, it is likely that Mxi2 binds
to nucleoporins through this same region, although with a
higher afﬁnity than ERK1/2, B60 vs B200nM (Whitehurst
et al, 2002). In agreement, we demonstrate that Mxi2 can
displace ERK1/2 from binding to nucleoporins. In support of
this notion, using the in vitro nuclear import assay, we have
observed that excess Mxi2 can prevent ERK2 nuclear import.
Even though p38a also possesses an FXF-binding region, it
cannot promote ERKs nuclear translocation, probably owing
to its low afﬁnity towards ERK1/2, compared with Mxi2
(Sanz-Moreno et al, 2003).
The relevance of the inﬂuence of Mxi2 on ERK1/2 binding
to the NPC is also highlighted by its antagonism with PEA15,
which prevents ERK1/2 nuclear entry by interfering with
ERK1/2 binding to nucleoporins (Whitehurst et al, 2004).
Mxi2 can overcome this inhibition and promote ERK1/2
nuclear translocation even in the presence of PEA15. Mxi2
antagonistic effects on PEA15 can be explained by its
ability to outcompete this protein for binding to ERK1/2, as
expected from the reported in vitro binding afﬁnities that
Mxi2 and PEA15 display for ERK1/2: 20nM (Sanz-Moreno
et al, 2003) and 200 nM (Callaway et al, 2005), respectively.
Along these lines, our results indicate that the association
between Mxi2 and ERK2 is mediated through the Insert
region, similar to PEA15 (Whitehurst et al, 2004), thus
demonstrating that Mxi2 and PEA15 share a common
binding site on ERK1/2. Interestingly, it has been proposed
that PEA15 C-terminal 121–127 amino acids, whereby it
binds to ERK1/2, constitute a reverse D domain, with a
consensus sequence: R/K-fa-X3/4-fb (where f are Leu, Ile
or Val) (Callaway et al, 2005). Noticeably, the Mxi2
C-terminus, which mediates its interaction with ERK1/2
(Sanz-Moreno et al, 2003), displays a very similar sequence:
K-fa-X5-fb.
ERK1/2 lack a canonical NLS and have not been found
associated with importins (Adachi et al, 1999). Even though
canonical ERK1/2 nuclear translocation can take place
independently of NPC functionality and Ran (Adachi et al,
1999), our results show that Mxi2-mediated ERK1/2 nuclear
transport is dependent on NPC integrity and this GTPase,
as it is inhibited by WGA and a Ran inhibitory mutant. The
requirement for energy for Mxi2-mediated transport is further
Nup
-Energy independent
-Ran independent
-Energy dependent
-Ran dependent
Cyt.
Nuc.
Nup
Cyt.
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ERK
N
C
Mitogenic stimulationA
B PEA 15
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Figure 9 Model for Mxi2-mediated ERK1/2 nuclear translocation.
As described in Discussion, (A) ERK1/2 nuclear translocation under
mitogenic stimulation in the absence of Mxi2. (B) ERK1/2 nuclear
translocation in the presence of Mxi2, without stimulation. Hatched
boxes: ERK-binding sites in nucleoporins. Dotted boxes: homolo-
gous hydrophobic regions in Mxi2 and ERK1/2.
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supported by our results showing that Mxi2 effects on ERK2
nuclear accumulation require cytosolic factors. Even though
Mxi2 does not have an NLS either, at this point, it cannot be
discarded that the Mxi2–ERK complex could somehow bind
to other proteins that possess that motif, thereby facilitating
further its entry to the nucleus.
An enhanced interaction with the NPC by the ERK–Mxi2
complex is likely to be the mechanism whereby Mxi2
promotes ERK1/2 nuclear accumulation. Another possibility
worth considering is the blockade of ERK1/2 nuclear export.
We have previously shown that Mxi2 sustains the levels of
nuclear, phosphorylated ERK1/2 (Sanz-Moreno et al, 2003).
As a consequence, the formation of ERK export complexes
would be delayed and ERK1/2 would be retained for longer
periods in the nucleus. However, our results clearly demon-
strate that Mxi2 can induce the nuclear accumulation of
ERK1/2 irrespective of their phosphorylation state.
Herein, we demonstrate that Mxi2 can promote ERK1/2
massive translocation into the nucleus, under starvation
conditions, in the absence of any additional stimulation.
Moreover, we have found that Mxi2 is capable of inducing
the nuclear translocation of unphosphorylatable ERK2 mu-
tants as efﬁciently as that of wild-type ERK2. Our data clearly
show that ERK1/2 can be transported into the nucleus in an
unphosphorylated form. This notion is further supported
by our results showing that Mxi2 can promote the nuclear
entry of monomeric ERK2. Thus, even though ERK1/2 phos-
phorylation can be sufﬁcient to trigger their nuclear import
in transformed cells (Lenormand et al, 1993), such an
event does not appear not be an essential requirement and,
under the right circumstances, unphosphorylated ERK1/2
can also be translocated into the nucleus. Our results point
to Mxi2 as a unique protein in retaining unphosphorylated
ERK1/2 in the nucleus.
Even though the biological rationale that underlies
the stimulus-independent nucleocytoplasmic distribution of
ERK1/2, as undertaken by Mxi2, is largely unknown, we
demonstrate that altering such an event can have profound
physiological implications, as evidenced by its effects on
cellular proliferation and by the association of Mxi2 over-
expression and ERK1/2 redistribution to renal tumors.
The currently accepted model for ERK1/2 distribution
postulates that in the absence of stimuli, unphosphorylated
ERK1/2 are retained at the cytoplasm through their interac-
tion with MEK and other cytoplasmic anchors (Fukuda et al,
1997b; Blanco-Aparicio et al, 1999). It would be expected that
in order to promote ERK1/2 nuclear entry without stimu-
lation, Mxi2 should be able to withdraw ERK1/2 from their
complexes with MEK. However, our results indicate other-
wise. This would seem at odds with the weak afﬁnity that
MEK displays for ERK1/2 in vitro (Kd¼ 10–15 mM) (Bardwell
et al, 2001) compared with Mxi2. One likely explanation for
this discrepancy could be that in physiological contexts MEK–
ERK afﬁnity is much greater, probably as a consequence of
the stabilizing effect of other proteins, such as scaffolds.
Another possibility could be that the presence of MEK–ERK
scaffolds could pose some degree of structural hindrance for
the interaction of ERK with Mxi2. On the other hand, a recent
model suggests that ERK1/2 nucleocytoplasmic distribution
would be primarily controlled by changes in the afﬁnity of
ERK1/2 towards its nuclear and cytoplasmic anchors and
hints for the existence of signiﬁcant amounts of uncomplexed
ERK1/2 in both compartments (Burack and Shaw, 2005;
Callaway et al, 2005). Under such premises, Mxi2 could
bring about ERK1/2 nuclear translocation by the recruitment
of the uncomplexed cytoplasmic fraction, without signiﬁ-
cantly affecting the fraction bound to MEK.
In summary, we propose a model for Mxi2-mediated
ERK1/2 nuclear translocation, as depicted in Figure 9: (a)
In the absence of Mxi2 and under mitogenic stimulation,
ERK1/2 translocate to the nucleus through the interaction
with NPC, taking place between ERK-binding sites at nucleo-
porins and ERK1/2 hydrophobic residues. Such a process
would occur independently of energy and without the
participation of Ran and subject to inhibition by PEA15.
(b) The presence of Mxi2 is sufﬁcient to drive ERK1/2 into
the nucleus, even without stimulation. Mxi2 constitutively
binds to ERK1/2, this interaction taking place through the
Mxi2 C-terminus and ERK1/2 Insert region. Hydrophobic
residues are conserved in Mxi2, whereby it binds ERK-bind-
ing sites in nucleoporins, although with much higher afﬁnity.
Mxi2 transports ERK1/2 into the nucleus by a high-efﬁciency
mechanism that is dependent on energy and Ran and is
unaffected by PEA15. In this respect, we have unveiled
Mxi2 as a unique protein in its role of promoting stimulus-
independent ERK1/2 nuclear import.
Materials and methods
Plasmids
We have previously described the vectors encoding for HA-Mxi2,
HA-Mxi2D17, FLAG-MKK3 and FLAG-MKK6 and GST-Mxi2, GST-
p38 and GST-ERK2 (Sanz-Moreno et al, 2003); ERK2 H176 L4A
(Khokhlatchev et al, 1998); ERK2 D241–272 and Y261N (Whitehurst
et al, 2004). HA-ERK2 AEF (Wolf et al, 2001) was provided
by R Seger, FLAG-PEA15 by H Chneiweiss and Ran Q69L by A
Wittinghofer. Mxi2 E293A was generated by PCR site-directed
mutagenesis. Zinc-inducible Mxi2 constructs were subcloned in MT
CB6, driven by the sheep metallothionein promoter. To generate
ERK2-NLS, SV40T antigen nuclear localization signal (PKKKRKV)
was introduced by PCR directly downstream of ERK2 last codon.
Cell culture and transfection
COS7 and MDCK cells were grown in DMEM–10% FCS. Cells were
transfected by the calcium phosphate technique (Sanz-Moreno et al,
2003). Wheat germ agglutinin and UO126 were from Sigma.
Clinical samples
Samples from renal tumors and corresponding healthy tissue were
obtained directly from surgeries performed at the Department of
Urology, Hospital Universitario Marque´s de Valdecilla (Santander,
Spain), in accordance with the center and the EEC Ethical
Regulations.
Immunoblotting and immunoprecipitations
These were performed as described (Sanz-Moreno et al, 2003).
Mouse monoclonals anti -HA, anti-Myc and anti-FLAG were from
Babco. Mouse monoclonals anti-ERK1/2 and anti-phospho-ERK
from Santa Cruz and Cell Signaling. Rabbit polyclonals anti-
Rho-GDI, anti-MEK, anti-Lamin A and anti-p38 (C terminus) were
from Santa Cruz. Rabbit polyclonal anti-Ran was from Dr JL Rosa
(Barcelona). The anti-Mxi2 polyclonal antibody was generated as
described (Esparis-Ogando et al, 2002), immunizing rabbits with a
peptide for Mxi2 unique 17-amino-acid C-terminus.
Cellular proliferation assays
These assays were performed as described (Ajenjo et al, 2004).
Subcellular fractionations
These were performed as described (Ajenjo et al, 2004).
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Nuclear Import assays
These assays were performed as described (Whitehurst et al, 2002).
Immunoﬂuorescences
These were performed as described (Ajenjo et al, 2004).
In vitro protein binding assays
These assays were performed basically as described previously
(Sanz-Moreno et al, 2003), using 200ng of GST-Nup 153c. Bound
ERK was quantitated by densitometry, using the program NIH
Image 1.61. Analyses of the results were performed and plotted
using the program GraphPad Prism 3 (GraphPad Software Inc.).
Mxi2 knockdown
The region comprising exon 110 of canine p38 was sequenced by
PCR using DNA from MDCK cells. Flanking primers annealing to
exons 11 and 12 were designed based on the p38 canine sequence
(GenBank #AF003597). A sense–antisense 19-base oligonucleotide,
targeting Mxi2 at nucleotides 888–907 (amino acids 282–287),
separated by a hairpin, was cloned into pSUPER retro and
transfected into MDCK. After selection in puromycin for 3 weeks,
clones were selected by virtue of their decreased Mxi2 expression
levels. The sequences of the inhibitory and control oligonucleotides
are available upon request.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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